17 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... Practice Guidelines and ... #HeartFailure #Management ... #CHF #guideline ... #treatment #algorithm
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... - Observe and ... disease or CHF) ... #management #cardiology ... #algorithm
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Treatment Algorithm ... iron #deficiency #CHF ... heartfailure #diagnosis #management ... #algorithm #cardiology ... #treatment #guidelines
Algorithm for Treatment of Chronic Thromboembolic Disease (CTEPH)
Initial Imaging for Screening - V/Q scan - 90-100%
Algorithm for Treatment ... scan - 90-100% se and ... karanpdesai #cteph #management ... #algorithm #cardiology ... #pulmonary #treatment
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
STAGES of CHF (A ... sometimes advanced treatment ... Treatments may include ... #Management #Cardiology ... Stages #ACCAHA #Algorithm
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... /diagnosis and treatment ... Iron #Deficiency #Management ... Diagnosis #HFrEF #sCHF ... #HeartFailure #Cardiology
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Ejection Fraction: Management ... hypertension, pulmonary ... ineffective) #Management ... #Cardiology #HFpEF ... #Treatment #HeartFailure
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
severe bleeding and ... #management #algorithm ... #pharmacology #treatment ... #decisionaid #cardiology ... #hematology #warfarin
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... Currently, edoxaban and ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... sepsis), PE, DAH, CHF ... APML #diagnosis #management ... #hematology #oncology